First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
34.24
-0.22 (-0.64%)
Apr 16, 2026, 10:57 AM EDT - Market open
FTXH Holdings Information
FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Merck & Co. stock at 7.28%, Johnson & Johnson at 7.26%, Bristol-Myers Squibb Company at 7.00%, AbbVie at 6.81%, and Eli Lilly and Company at 6.59%.
Total Holdings
51
Top 10 Percentage
52.81%
Asset Class
Equity
ETF Category
Health
Assets
28.89M
PE Ratio
18.59
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRK | Merck & Co., Inc. | 7.28% |
| 2 | JNJ | Johnson & Johnson | 7.26% |
| 3 | BMY | Bristol-Myers Squibb Company | 7.00% |
| 4 | ABBV | AbbVie Inc. | 6.81% |
| 5 | LLY | Eli Lilly and Company | 6.59% |
| 6 | PFE | Pfizer Inc. | 3.68% |
| 7 | REGN | Regeneron Pharmaceuticals, Inc. | 3.63% |
| 8 | GILD | Gilead Sciences, Inc. | 3.54% |
| 9 | CAH | Cardinal Health, Inc. | 3.52% |
| 10 | BIIB | Biogen Inc. | 3.50% |
| 11 | VTRS | Viatris Inc. | 3.50% |
| 12 | ZTS | Zoetis Inc. | 3.47% |
| 13 | AMGN | Amgen Inc. | 3.40% |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | 3.36% |
| 15 | UTHR | United Therapeutics Corporation | 3.21% |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 2.29% |
| 17 | INCY | Incyte Corporation | 2.27% |
| 18 | ILMN | Illumina, Inc. | 1.62% |
| 19 | EXEL | Exelixis, Inc. | 1.60% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.53% |
| 21 | PTCT | PTC Therapeutics, Inc. | 1.35% |
| 22 | CRL | Charles River Laboratories International, Inc. | 1.30% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.19% |
| 24 | NBIX | Neurocrine Biosciences, Inc. | 1.17% |
| 25 | HALO | Halozyme Therapeutics, Inc. | 1.15% |
As of Apr 13, 2026